Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients.
Paolicelli D, Ruggieri M, Manni A, Gargano CD, Carleo G, Palazzo C, Iaffaldano A, Bollo L, Guerra T, Saracino A, Frigeri A, Iaffaldano P, Trojano M. Paolicelli D, et al. Among authors: bollo l. Brain Sci. 2022 Nov 22;12(12):1595. doi: 10.3390/brainsci12121595. Brain Sci. 2022. PMID: 36552055 Free PMC article.
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes.
Simone M, Palazzo C, Mastrapasqua M, Bollo L, Pompamea F, Gabellone A, Marzulli L, Giordano P, De Giacomo A, Frigeri A, Ruggieri M, Margari L. Simone M, et al. Among authors: bollo l. Front Neurol. 2021 Nov 11;12:754518. doi: 10.3389/fneur.2021.754518. eCollection 2021. Front Neurol. 2021. PMID: 34867740 Free PMC article.
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
Pappolla A, Auger C, Sao-Aviles A, Tur C, Rodriguez-Barranco M, Cobo-Calvo Á, Mongay-Ochoa N, Rodríguez-Acevedo B, Zabalza A, Midaglia L, Carbonell-Mirabent P, Carvajal R, Castilló-Justribó J, Braga N, Bollo L, Vidal-Jordana A, Arrambide G, Nos C, Salerno A, Galán I, Comabella M, Sastre-Garriga J, Tintoré M, Rovira A, Montalban X, Río J. Pappolla A, et al. Among authors: bollo l. Mult Scler. 2024 Mar 29:13524585241240653. doi: 10.1177/13524585241240653. Online ahead of print. Mult Scler. 2024. PMID: 38551315
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Bollo L, Arrambide G, Cobo-Calvo A, Alvarez JV, Alberich M, Cabello S, Castilló J, Galan I, Midaglia LS, Acevedo BR, Zabalza A, Pappolla A, Mongay Ochoa N, Tintore M, Rio J, Comabella M, Tur C, Auger C, Sastre-Garriga J, Rovira A, Montalban X, Pareto D, Vidal-Jordana A. Bollo L, et al. Neurology. 2024 Apr 9;102(7):e209156. doi: 10.1212/WNL.0000000000209156. Epub 2024 Mar 6. Neurology. 2024. PMID: 38447105
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.
Carvajal R, Tur C, Martínez-Gómez X, Bollo L, Esperalba J, Rodriguez M, Pappolla A, Cobo-Calvo A, Carbonell P, Borras-Bemejo B, Río J, Castilló J, Braga N, Mongay-Ochoa N, Rodrigo-Pendás JÁ, Vidal-Jordana Á, Arrambide G, Rodríguez-Acevedo B, Zabalza A, Midaglia L, Galán I, Comabella M, Sastre-Garriga J, Montalban X, Tintoré M, Otero-Romero S. Carvajal R, et al. Among authors: bollo l. Mult Scler. 2023 Dec;29(14):1841-1848. doi: 10.1177/13524585231200303. Epub 2023 Sep 20. Mult Scler. 2023. PMID: 37728389 Free PMC article.
13 results